In our validation cohort, we identified a distinctive subgroup of eight MASLD patients co-harboring two pathogenic variants: PNPLA3 rs738409 (I148M) and ABCC8 rs146378237 (R653Q), all of whom were also diagnosed with T2DM. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.